Monopar adds ex-KalVista CCO Nicole Sweeny to board
MNPR•Board and leadership updates
- Monopar added former KalVista Chief Commercial Officer Nicole Sweeny to its board, elected at the June 22, 2026 annual meeting.
- The commercial team was expanded with Sharon Funk named SVP, Sales and Marketing; she most recently supported Avadel’s LUMRYZ commercialization.
- Daniel Olmstead was appointed SVP, Market Access, Distribution and Patient Services; he most recently supported launches at Ardelyx and Akebia.
Launch readiness for ALXN1840
The moves support launch readiness for Wilson disease drug ALXN1840; NDA submission is targeted for mid-2026.
